{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:09:37Z","timestamp":1791360577051,"version":"4.3.1"},"reference-count":144,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T00:00:00Z","timestamp":1694304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jtumed.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T16:05:59Z","timestamp":1695225959000},"page":"35-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-4883","authenticated-orcid":false,"given":"Hayder R.","family":"Salman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5207-383X","authenticated-orcid":false,"given":"Adeeb A.","family":"Alzubaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa H.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein A.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","article-title":"Psoriasis prevalence and severity by expert elicitation","volume":"11","author":"Papp","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jtumed.2023.09.002_bib2","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jtumed.2023.09.002_bib3","doi-asserted-by":"crossref","first-page":"2249834","DOI":"10.1155\/2022\/2249834","article-title":"Psoriasis between autoimmunity and oxidative stress: changes induced by different therapeutic approaches","volume":"2022","author":"Medovic","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41065-022-00233-0","article-title":"Identification of key apoptosis-related genes and immune infiltration in the pathogenesis of psoriasis","volume":"159","author":"Zou","year":"2022","journal-title":"Hereditas"},{"issue":"17","key":"10.1016\/j.jtumed.2023.09.002_bib6","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.3390\/ijms22179449","article-title":"Purinergic signaling and inflammasome activation in psoriasis pathogenesis","volume":"22","author":"Ferrari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtumed.2023.09.002_bib7","first-page":"73","article-title":"Updated perspectives on keratinocytes and psoriasis: keratinocytes are more than innocent bystanders","volume":"12","author":"Ortiz-Lopez","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.jtumed.2023.09.002_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01764","article-title":"Adaptive and innate immunity in psoriasis and other inflammatory disorders","volume":"10","author":"Sch\u00f6n","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/CCID.S356801","article-title":"Role of Fetuin-A in the pathogenesis of psoriasis and its potential clinical applications","volume":"15","author":"Chekol Abebe","year":"2022","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"18","key":"10.1016\/j.jtumed.2023.09.002_bib10","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.3390\/ijms21186791","article-title":"Psoriasis and antimicrobial peptides","volume":"21","author":"Takahashi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100116","article-title":"The relapse of psoriasis: mechanisms and mysteries","volume":"2","author":"Tian","year":"2022","journal-title":"JID Innov"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib12","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191397","article-title":"Interleukin-17 cytokines: effectors and targets in psoriasis-A breakthrough in understanding and treatment","volume":"217","author":"Prinz","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtumed.2023.09.002_bib13","series-title":"Different aspects of psoriasis: comorbidity, comedication and disease biomarkers","author":"Duvetorp","year":"2021"},{"issue":"18","key":"10.1016\/j.jtumed.2023.09.002_bib14","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J Mol Si"},{"key":"10.1016\/j.jtumed.2023.09.002_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.phrs.2015.06.001","article-title":"Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC\/IL-17A pathway modulation","volume":"99","author":"Nadeem","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtumed.2023.09.002_bib16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellsig.2017.02.014","article-title":"GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model","volume":"33","author":"Nadeem","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.jtumed.2023.09.002_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopha.2018.12.060","article-title":"Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis","volume":"111","author":"Alzahrani","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtumed.2023.09.002_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pnpbp.2017.12.015","article-title":"Systemic inflammation in asocial BTBR T(+) tf\/J mice predisposes them to increased psoriatic inflammation","volume":"83","author":"Nadeem","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jtumed.2023.09.002_bib20","doi-asserted-by":"crossref","first-page":"173088","DOI":"10.1016\/j.ejphar.2020.173088","article-title":"Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells","volume":"877","author":"Al-Harbi","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib21","doi-asserted-by":"crossref","first-page":"14244","DOI":"10.1038\/s41598-022-18671-1","article-title":"A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB\/c mice","volume":"12","author":"Jamshaid","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jtumed.2023.09.002_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"10.1016\/j.jtumed.2023.09.002_bib141","first-page":"3160","article-title":"Effects of montelukast on imiquimod-induced model of psoriasis In mice","volume":"8","author":"Al-juhaishi","year":"2021","journal-title":"NVEO-Nat Volatiles Essent Oils J|NVEO"},{"issue":"9","key":"10.1016\/j.jtumed.2023.09.002_bib23","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Van Der Fits","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.jtumed.2023.09.002_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","article-title":"Advanced characterization of imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Jabeen","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtumed.2023.09.002_bib25","doi-asserted-by":"crossref","first-page":"599947","DOI":"10.3389\/fimmu.2020.599947","article-title":"Interleukin 17 promotes expression of alarmins S100A8 and S100A9 during the inflammatory response of keratinocytes","volume":"11","author":"Christmann","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib27","first-page":"252","article-title":"The effect of lenalidomide ointment on TNF-\u03b1 tissue levels in mice with imiquimod-induced psoriasis","volume":"64","author":"Sajjad","year":"2023","journal-title":"J Fac Med Baghdad"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2009.252","article-title":"A role for TGF\u03b2 signaling in the pathogenesis of psoriasis","volume":"130","author":"Han","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/biomedicines10051133","article-title":"Significantly altered serum levels of NAD, AGE, RAGE, CRP, and elastin as potential biomarkers of psoriasis and aging-a case-control study","volume":"10","author":"Karas","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtumed.2023.09.002_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jddst.2018.12.020","article-title":"Chaulmoogra oil based methotrexate loaded topical nanoemulsion for the treatment of psoriasis","volume":"49","author":"Rajitha","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib31","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s13555-021-00600-1","article-title":"Beyond-mild psoriasis: a consensus statement on calcipotriol and betamethasone dipropionate foam for the topical treatment of adult patients","volume":"11","author":"Aschoff","year":"2021","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40801-021-00290-3","article-title":"Treatment patterns and pharmacoutilization in patients affected by psoriasis: an observational study in an Italian real-world setting","volume":"9","author":"Perrone","year":"2022","journal-title":"Drugs Real World Outcomes"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/2229-5178.209622","article-title":"Topical therapies in psoriasis","volume":"8","author":"Torsekar","year":"2017","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000512930","article-title":"Topical treatment of psoriasis vulgaris: the Swiss treatment pathway","volume":"237","author":"Maul","year":"2021","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jtumed.2023.09.002_bib36","first-page":"39","article-title":"Biologic treatments of psoriasis: an update for the clinician","volume":"15","author":"Brownstone","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.jtumed.2023.09.002_bib37","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/CCID.S364640","article-title":"Guselkumab, risankizumab, and tildrakizumab in the management of psoriasis: a review of the real-world evidence","volume":"15","author":"Ruggiero","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"10.1016\/j.jtumed.2023.09.002_bib38","article-title":"Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?","volume":"51","author":"Metko","year":"2023","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.jtumed.2023.09.002_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2147\/JEP.S265632","article-title":"Experimental pharmacological management of psoriasis","volume":"13","author":"Campione","year":"2021","journal-title":"J Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib40","doi-asserted-by":"crossref","first-page":"2014296","DOI":"10.1080\/19420862.2021.2014296","article-title":"Antibodies to watch in 2022","volume":"14","author":"Kaplon","year":"2022","journal-title":"mAbs"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/jdv.18820","article-title":"Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: results from the Effisayil 1 study","volume":"37","author":"Navarini","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40259-022-00569-z","article-title":"Biologic and small-molecule therapies for moderate-to-severe psoriasis: focus on psoriasis comorbidities","volume":"37","author":"Jiang","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.jtumed.2023.09.002_bib43","first-page":"1","article-title":"Updates in treatment and impact of nail psoriasis","author":"Iorizzo","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"10.1016\/j.jtumed.2023.09.002_bib44","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/epi.16394","article-title":"Personalized medicine: vinpocetine to reverse effects of GABRB3 mutation","volume":"60","author":"Billakota","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.jtumed.2023.09.002_bib45","first-page":"17","article-title":"Vinpocetine: hype, hope and hurdles towards neuroprotection","author":"Vora","year":"2013","journal-title":"Asian J Pharm Res Dev"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/pharmaceutics14040836","article-title":"Lipid-based nanocarriers for neurological disorders: a review of the state-of-the-art and therapeutic success to date","volume":"14","author":"Witika","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtumed.2023.09.002_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.22159\/ajpcr.2017.v10s4.21343","article-title":"Comparative evaluation of different doses of vinpocetine alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats","author":"Datt","year":"2017","journal-title":"Asian J Pharmaceut Clin Res"},{"issue":"21","key":"10.1016\/j.jtumed.2023.09.002_bib48","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1073\/pnas.0914414107","article-title":"Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism","volume":"107","author":"Jeon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtumed.2023.09.002_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2015.05.007","article-title":"Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-\u03baB","volume":"237","author":"Ruiz-Miyazawa","year":"2015","journal-title":"Chem Biol Interact"},{"issue":"2\u20134","key":"10.1016\/j.jtumed.2023.09.002_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1740925X12000129","article-title":"TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation","volume":"7","author":"Zhao","year":"2011","journal-title":"Neuron Glia Biol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fnins.2020.00223","article-title":"Vinpocetine protects against cerebral ischemia-reperfusion injury by targeting astrocytic connexin43 via the PI3K\/AKT signaling pathway","volume":"14","author":"Zhao","year":"2020","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/08820139.2016.1248561","article-title":"Vinpocetine inhibited the CpG oligodeoxynucleotide-induced immune response in plasmacytoid dendritic cells","volume":"46","author":"Feng","year":"2017","journal-title":"Immunol Invest"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2013.03.092","article-title":"Vinpocetine attenuates lipid accumulation and atherosclerosis formation","volume":"434","author":"Cai","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtumed.2023.09.002_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exer.2014.07.003","article-title":"Vinpocetine inhibits amyloid-beta induced activation of NF-\u03baB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells","volume":"127","author":"Liu","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtumed.2023.09.002_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neulet.2014.02.045","article-title":"Anti-inflammatory effects of vinpocetine on the functional expression of nuclear factor-kappa B and tumor necrosis factor-alpha in a rat model of cerebral ischemia\u2013reperfusion injury","volume":"566","author":"Wang","year":"2014","journal-title":"Neurosci Lett"},{"issue":"12","key":"10.1016\/j.jtumed.2023.09.002_bib56","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.4049\/jimmunol.1401489","article-title":"Vinpocetine inhibits Streptococcus pneumoniae\u2013induced upregulation of mucin MUC5AC expression via induction of MKP-1 phosphatase in the pathogenesis of otitis media","volume":"194","author":"Lee","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12975-017-0549-z","article-title":"Vinpocetine inhibits NF-\u03baB-dependent inflammation in acute ischemic stroke patients","volume":"9","author":"Zhang","year":"2018","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jtumed.2023.09.002_bib58","doi-asserted-by":"crossref","first-page":"110236","DOI":"10.1016\/j.intimp.2023.110236","article-title":"Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines","volume":"119","author":"Bharti Sonkar","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib59","first-page":"1","article-title":"Development, optimization, and in\u00a0vitro evaluation of atorvastatin calcium and vinpocetine codelivery by solid lipid nanoparticles for cancer therapy","volume":"7","author":"Lala","year":"2021","journal-title":"Future J Pharm Sci"},{"issue":"10","key":"10.1016\/j.jtumed.2023.09.002_bib60","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s10495-012-0743-0","article-title":"Vinpocetine inhibits breast cancer cells growth in vitro and in vivo","volume":"17","author":"Huang","year":"2012","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.jtumed.2023.09.002_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23046","article-title":"Renoprotective effect of vinpocetine against ischemia\/reperfusion injury: modulation of NADPH oxidase\/Nrf2, IKK\u03b2\/NF-\u03baB p65, and cleaved caspase-3 expressions","volume":"36","author":"Azouz","year":"2022","journal-title":"J Biochem Mol Toxicol"},{"issue":"12","key":"10.1016\/j.jtumed.2023.09.002_bib151","article-title":"Effects of Vinpocetine on Renal Ischemia Reperfusion Injury in a Male Rat Model","volume":"11","author":"Abbas","year":"2020","journal-title":"Sys Rev Pharm"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib62","article-title":"Review on vinpocetine","volume":"11","author":"Dubey","year":"2020","journal-title":"Int J Pharm Life Sci"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib63","first-page":"381","article-title":"Ethosomes as delivery system for transdermal administration of vinpocetine","volume":"68","author":"Mao","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.jtumed.2023.09.002_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/DDDT.S189105","article-title":"Formulation and clinical investigation of optimized vinpocetine lyoplant-tabs: new strategy in development of buccal solid dosage form","volume":"13","author":"Ahmed","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib66","first-page":"211","article-title":"Updates of recent vinpocetine research in treating cardiovascular diseases","volume":"2","author":"Zhang","year":"2020","journal-title":"J\u00a0Cell Immunol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib74","series-title":"Profiles of drug substances, excipients and related methodology","first-page":"1","article-title":"Chapter One - Vinpocetine (A comprehensive profile)","author":"Khalil","year":"2022"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12950-023-00330-5","article-title":"Anti-inflammatory therapy of atherosclerosis: focusing on IKK\u03b2","volume":"20","author":"Gan","year":"2023","journal-title":"J Inflamm"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib68","first-page":"9","article-title":"Effects of vinpocetine on atopic dermatitis after administration via three different routes in HR-1 hairless mice","volume":"77","author":"Kang","year":"2022","journal-title":"Pharmazie"},{"issue":"10","key":"10.1016\/j.jtumed.2023.09.002_bib69","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s11064-019-02871-9","article-title":"The mitochondrial targets of neuroprotective drug vinpocetine on primary neuron cultures, brain capillary endothelial cells, synaptosomes, and brain mitochondria","volume":"44","author":"Svab","year":"2019","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jphs.2021.01.010","article-title":"Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study","volume":"145","author":"Guti\u00e9rrez-Farf\u00e1n","year":"2021","journal-title":"J Pharmacol Sci"},{"issue":"46","key":"10.1016\/j.jtumed.2023.09.002_bib71","doi-asserted-by":"crossref","first-page":"80315","DOI":"10.18632\/oncotarget.20699","article-title":"Vinpocetine alleviate cerebral ischemia\/reperfusion injury by down-regulating TLR4\/MyD88\/NF-\u03baB signaling","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtumed.2023.09.002_bib72","doi-asserted-by":"crossref","first-page":"6687386","DOI":"10.1155\/2021\/6687386","article-title":"Neuroprotective phytochemicals in experimental ischemic stroke: mechanisms and potential clinical applications","volume":"2021","author":"Xu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jtumed.2023.09.002_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2017.11.041","article-title":"An update on vinpocetine: new discoveries and clinical implications","volume":"819","author":"Zhang","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib75","doi-asserted-by":"crossref","first-page":"452","DOI":"10.30574\/wjarr.2022.13.1.0048","article-title":"A\u00a0review on emerging applications of emulgel as topical drug delivery system","volume":"13","author":"Sabalingam","year":"2022","journal-title":"World J Adv Res Rev"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsps.2011.08.001","article-title":"Formulation and evaluation of mefenamic acid emulgel for topical delivery","volume":"20","author":"Khullar","year":"2012","journal-title":"Saudi Pharm J"},{"issue":"8","key":"10.1016\/j.jtumed.2023.09.002_bib77","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/03639045.2021.1993889","article-title":"Emulgel: an effective drug delivery system","volume":"47","author":"Talat","year":"2021","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib78","first-page":"3","article-title":"Preparation of a topical product from Allium sativum retrieved from Iranian traditional medicine","volume":"6","author":"Jahandideh","year":"2019","journal-title":"Res J Pharmacogn"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib79","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10787-022-01131-7","article-title":"Development and evaluation emulgel for effective management of the imiquimod-induced psoriasis","volume":"31","author":"Sulthana","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"12","key":"10.1016\/j.jtumed.2023.09.002_bib80","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.jsps.2020.11.011","article-title":"Formulation and evaluation of Ocimum basilicum-based emulgel for wound healing using animal model","volume":"28","author":"Khan","year":"2020","journal-title":"Saudi Pharm J"},{"issue":"6","key":"10.1016\/j.jtumed.2023.09.002_bib81","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4314\/tjpr.v12i6.3","article-title":"Evaluation of topical gel bases formulated with various essential oils for antibacterial activity against methicillin-resistant Staphylococcus aureus","volume":"12","author":"Shukr","year":"2013","journal-title":"Trop J Pharm Res"},{"issue":"6","key":"10.1016\/j.jtumed.2023.09.002_bib82","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1101\/pdb.prot073411","article-title":"Manual hematoxylin and eosin staining of mouse tissue sections","volume":"2014","author":"Cardiff","year":"2014","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.jtumed.2023.09.002_bib83","doi-asserted-by":"crossref","first-page":"110696","DOI":"10.1016\/j.biopha.2020.110696","article-title":"Luteolin attenuates imiquimod\u2013induced psoriasis-like skin lesions in BALB\/c mice via suppression of inflammation response","volume":"131","author":"Zhou","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.jtumed.2023.09.002_bib84","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1096\/fj.201800354","article-title":"Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte-derived chemokine expression and neutrophil infiltration","volume":"32","author":"Lin","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.jtumed.2023.09.002_bib85","series-title":"Understanding medical biostatistics, How to practice academic medicine and publish from developing countries?","first-page":"95","author":"Nundy","year":"2022"},{"key":"10.1016\/j.jtumed.2023.09.002_bib86","article-title":"Effect of metformin gel against imiquimod\u2013induced psoriasis in mice","author":"Alsaedi","year":"2019","journal-title":"Int J Res Pharm Sci"},{"key":"10.1016\/j.jtumed.2023.09.002_bib87","first-page":"1","article-title":"The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice","author":"Salman","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib88","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"42(special issue):","key":"10.1016\/j.jtumed.2023.09.002_bib140","first-page":"362","article-title":"The attenuated effects of cimifugin on imiquimod-induced model of psoriasis in mice","author":"Abbas","year":"2023","journal-title":"Lat Am J Pharm"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/gels9020112","article-title":"In vitro and in vivo investigation of a dual-targeted nanoemulsion gel for the amelioration of psoriasis","volume":"9","author":"Khan","year":"2023","journal-title":"Gels"},{"issue":"8","key":"10.1016\/j.jtumed.2023.09.002_bib90","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/09546634.2020.1724250","article-title":"Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites","volume":"32","author":"Hoegsberg","year":"2021","journal-title":"J Dermatol Treat"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020383","article-title":"Novel dermal delivery cargos of clobetasol propionate: an update","volume":"14","author":"Nair","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtumed.2023.09.002_bib92","series-title":"Comprehensive dermatologic drug therapy","author":"Wolverton","year":"2019"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib93","first-page":"22","article-title":"Topical corticosteroid therapy for psoriasis-a review of clobetasol propionate 0.025% cream and the clinical relevance of penetration modification","volume":"13","author":"Del Rosso","year":"2020","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"10","key":"10.1016\/j.jtumed.2023.09.002_bib94","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40261-021-01072-z","article-title":"Steroid phobia: is there a basis? A review of topical steroid safety, addiction and withdrawal","volume":"41","author":"Tan","year":"2021","journal-title":"Clin Drug Invest"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09546634.2020.1729335","article-title":"Long-term topical management of psoriasis: the road ahead","volume":"33","author":"Segaert","year":"2022","journal-title":"J Dermatol Treat"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib96","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jtumed.2023.09.002_bib97","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnad016","article-title":"Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?","author":"Pofi","year":"2023","journal-title":"Endocr Rev"},{"issue":"16","key":"10.1016\/j.jtumed.2023.09.002_bib98","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.7150\/ijbs.73915","article-title":"Reversion of glucocorticoid-induced senescence and collagen synthesis decrease by LY294002 is mediated through p38 in skin","volume":"18","author":"Le","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jtumed.2023.09.002_bib99","series-title":"Design of nanostructures for versatile therapeutic applications","first-page":"379","article-title":"Chapter 9 - Psoriasis vulgaris\u2014pathophysiology of the disease and its classical treatment versus new drug delivery systems","author":"Fernandes","year":"2018"},{"issue":"S3","key":"10.1016\/j.jtumed.2023.09.002_bib142","doi-asserted-by":"crossref","first-page":"171","DOI":"10.53730\/ijhs.v6nS3.5241","article-title":"Study the topical effect of six days use of different lycopene doses on imiquimod-induce psoriasis-like skin inflammation in mice","volume":"6","author":"Mohammed","year":"2022","journal-title":"Int J Health Sci"},{"issue":"11","key":"10.1016\/j.jtumed.2023.09.002_bib152","first-page":"524","article-title":"Effect of Topical Dipyridamole Gel in Comparison with Clobetasol on induced Psoriasis in Mice","volume":"2","author":"Ahmed","year":"2021","journal-title":"Inte J Drug Deliv Technol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/molecules20010335","article-title":"Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature","volume":"20","author":"Zhang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.jtumed.2023.09.002_bib101","series-title":"Method and compositions for treatment or prevention of inflammatory conditions","author":"Yan","year":"2016"},{"issue":"1\u20132","key":"10.1016\/j.jtumed.2023.09.002_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000506777","article-title":"Combination of vinpocetine and dexamethasone alleviates cognitive impairment in nasopharyngeal carcinoma patients following radiation injury","volume":"106","author":"Zhang","year":"2021","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib103","first-page":"13","article-title":"Vinpocetine\u2019s immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis","volume":"26","author":"Balaha","year":"2023","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/0960327120947453","article-title":"Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats","volume":"40","author":"Elnfarawy","year":"2021","journal-title":"Hum Exp Toxicol"},{"issue":"6","key":"10.1016\/j.jtumed.2023.09.002_bib105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0033-1343834","article-title":"Effects of vinpocetine on random skin flap survival in rats","volume":"29","author":"Xiao-Xiao","year":"2013","journal-title":"J\u00a0Reconstr Microsurg"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib106","first-page":"51","article-title":"Vinpocetine suppresses inflammatory and oxidative machineries in acute model of inflammation\u2014pivotal role of COX-2 signaling","volume":"4","author":"Twafik w","year":"2021","journal-title":"SVU-Int J Vet Sci"},{"key":"10.1016\/j.jtumed.2023.09.002_bib107","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6481812","article-title":"Repurposing of the nootropic drug vinpocetine as an analgesic and anti-inflammatory agent: evidence in a mouse model of superoxide anion-triggered inflammation","volume":"2019","author":"Lourenco-Gonzalez","year":"2019","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib108","first-page":"211","article-title":"Sildenafil and vinpocetine promote wound healing in diabetic rats","volume":"5","author":"Barakat","year":"2021","journal-title":"J\u00a0Adv Pharm Res"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ijms19010042","article-title":"The origin of skin dendritic cell network and its role in psoriasis","volume":"19","author":"Kim","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtumed.2023.09.002_bib110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2020.09.023","article-title":"Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice","volume":"179","author":"Nadeem","year":"2020","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.jtumed.2023.09.002_bib111","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169450","article-title":"Targeting immune cell trafficking and vascular endothelial cells in psoriasis","volume":"133","author":"Young","year":"2023","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtumed.2023.09.002_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02376","article-title":"Neutrophils in psoriasis","volume":"10","author":"Chiang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib113","article-title":"Role of neutrophils in psoriasis","volume":"2020","author":"Wang","year":"2020","journal-title":"J\u00a0Immunol Res"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118942","article-title":"Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-\u03baB activation in the paw and spinal cord","volume":"10","author":"Ruiz-Miyazawa","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251012","article-title":"Vinpocetine alleviates lung inflammation via macrophage inflammatory protein-1\u03b2 inhibition in an ovalbumin-induced allergic asthma model","volume":"16","author":"Choi","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib116","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1159\/000341451","article-title":"Vinpocetine inhibits oligodendroglial precursor cell differentiation","volume":"30","author":"Torres","year":"2012","journal-title":"Cell Physiol Biochem"},{"issue":"22","key":"10.1016\/j.jtumed.2023.09.002_bib117","doi-asserted-by":"crossref","first-page":"9921","DOI":"10.1073\/pnas.1005138107","article-title":"Vinpocetine as a potent antiinflammatory agent","volume":"107","author":"Medina","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib118","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/HYPERTENSIONAHA.110.164327","article-title":"Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1","volume":"57","author":"Giachini","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jtumed.2023.09.002_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2017.02.018","article-title":"Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase","volume":"46","author":"Al-Harbi","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib120","doi-asserted-by":"crossref","first-page":"113330","DOI":"10.1016\/j.biopha.2022.113330","article-title":"Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson\u2019s disease in Sprague Dawley rats","volume":"153","author":"Abu-Elfotuh","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib121","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/FJC.0000000000000945","article-title":"Vinpocetine attenuates ischemic stroke through inhibiting NLRP3 inflammasome expression in mice","volume":"77","author":"Han","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib122","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.imbio.2016.10.013","article-title":"Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A\/IL-17 receptor signaling in a murine model","volume":"222","author":"Al-Harbi","year":"2017","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib123","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11011-018-0256-9","article-title":"Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation","volume":"33","author":"Ishola","year":"2018","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib124","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4049\/jimmunol.1901299","article-title":"Vinpocetine suppresses Streptococcus pneumoniae\u2013induced inflammation via inhibition of ERK1 by CYLD","volume":"204","author":"Komatsu","year":"2020","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib125","doi-asserted-by":"crossref","DOI":"10.1590\/0001-3765202020200241","article-title":"Anti-inflammatory effects of vinpocetine in LPS-stimulated microglia via activation of AMPK","volume":"92","author":"Zhou","year":"2020","journal-title":"An Acad Bras Cienc"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J\u00a0Neuroinflammation"},{"issue":"5","key":"10.1016\/j.jtumed.2023.09.002_bib127","doi-asserted-by":"crossref","first-page":"FSO797","DOI":"10.2144\/fsoa-2021-0099","article-title":"Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19","volume":"8","author":"Al-kuraishy","year":"2022","journal-title":"Future Sci OA"},{"key":"10.1016\/j.jtumed.2023.09.002_bib128","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgad043","article-title":"Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1\/TGF-\u03b2\/Smad 2\/3 signalling pathways","author":"Vishwakarma","year":"2023","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jtumed.2023.09.002_bib129","first-page":"3821279","article-title":"The influence of adalimumab and cyclosporine A on the expression profile of the genes related to TGF\u03b2 signaling pathways in keratinocyte cells treated with lipopolysaccharide","volume":"2020","author":"Adwent","year":"2020","journal-title":"A, Mediators Inflamm"},{"key":"10.1016\/j.jtumed.2023.09.002_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.845892","article-title":"Indole-Based small molecules as potential therapeutic agents for the treatment of fibrosis","volume":"13","author":"Qin","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.jtumed.2023.09.002_bib153","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10557-017-6719-0","article-title":"Vinpocetine attenuates pathological cardiac remodeling by inhibiting cardiac hypertrophy and fibrosis","volume":"31","author":"Wu","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"issue":"46","key":"10.1016\/j.jtumed.2023.09.002_bib131","doi-asserted-by":"crossref","first-page":"80315","DOI":"10.18632\/oncotarget.20699","article-title":"Vinpocetine alleviate cerebral ischemia\/reperfusion injury by down-regulating TLR4\/MyD88\/NF-\u03baB signaling","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib132","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/s41467-022-31935-8","article-title":"Calcium\/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice","volume":"13","author":"Yong","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib133","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J Moci"},{"issue":"7","key":"10.1016\/j.jtumed.2023.09.002_bib134","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.1400205","article-title":"Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23\/IL-17 axis","volume":"193","author":"Works","year":"2014","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jtumed.2023.09.002_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043391","article-title":"Tyk2 targeting in immune-mediated inflammatory diseases","volume":"24","author":"Rusi\u00f1ol","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib136","first-page":"1","article-title":"A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.jtumed.2023.09.002_bib137","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1203475420960429","article-title":"Topical PDE-4 inhibitors are emerging for psoriasis treatment","volume":"25","author":"Ridha","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jtumed.2023.09.002_bib138","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.lanepe.2023.100639","article-title":"Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis\u2014a randomized controlled trial (PSORRO)","volume":"30","author":"Gyldenl\u00f8ve","year":"2023","journal-title":"Lancet Reg Health Europe"},{"issue":"3","key":"10.1016\/j.jtumed.2023.09.002_bib139","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.37506\/ijfmt.v15i3.15529","article-title":"Effect of topical\u00a0tadalafil gel in imiquimod-induced psoriasiform skin\u00a0inflammation in mice","volume":"15","author":"Ahmed","year":"2021","journal-title":"Indian J Forensic Med Toxicol"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S165836122300135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S165836122300135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:34:44Z","timestamp":1761647684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S165836122300135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S165836122300135X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2023.09.002","relation":{},"ISSN":["1658-3612"],"issn-type":[{"value":"1658-3612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}